Brokerages Set Clarivate PLC (NYSE:CLVT) PT at $3.22

Shares of Clarivate PLC (NYSE:CLVT) have been assigned a consensus rating of “Reduce” from the eight ratings firms that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell recommendation and five have assigned a hold recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $3.2167.

A number of brokerages have recently commented on CLVT. Citigroup lowered their price target on Clarivate from $4.25 to $2.80 and set a “neutral” rating for the company in a research note on Wednesday, March 4th. Wall Street Zen raised Clarivate from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Clarivate in a research note on Friday, March 27th. Barclays lowered their price target on Clarivate from $4.00 to $2.40 and set an “underweight” rating for the company in a research note on Wednesday, February 25th. Finally, Royal Bank Of Canada lowered their price target on Clarivate from $5.00 to $3.00 and set a “sector perform” rating for the company in a research note on Wednesday, February 25th.

Institutional Trading of Clarivate

Institutional investors and hedge funds have recently modified their holdings of the stock. Personal CFO Solutions LLC bought a new stake in Clarivate during the 1st quarter worth approximately $30,000. FreeGulliver LLC bought a new stake in Clarivate during the 1st quarter worth approximately $30,000. Principal Financial Group Inc. bought a new stake in Clarivate during the 1st quarter worth approximately $32,000. M&T Bank Corp bought a new stake in Clarivate during the 4th quarter worth approximately $34,000. Finally, Parallel Advisors LLC increased its stake in Clarivate by 94.2% during the 1st quarter. Parallel Advisors LLC now owns 13,786 shares of the company’s stock worth $35,000 after purchasing an additional 6,687 shares in the last quarter. 85.72% of the stock is owned by institutional investors.

Clarivate Stock Performance

Clarivate stock opened at $2.13 on Wednesday. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 0.89. Clarivate has a 1 year low of $1.66 and a 1 year high of $4.77. The company has a market cap of $1.36 billion, a PE ratio of -10.12 and a beta of 1.36. The company’s 50-day moving average is $2.50 and its two-hundred day moving average is $2.71.

Clarivate (NYSE:CLVT) last released its earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.04. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The company had revenue of $585.50 million for the quarter, compared to the consensus estimate of $569.50 million. During the same period in the prior year, the company posted $0.14 EPS. The company’s revenue was down 1.4% compared to the same quarter last year. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. Equities analysts anticipate that Clarivate will post 0.65 earnings per share for the current year.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.